Clinical evaluation of dithiothreitol in comparison with sonication for biofilm dislodgement in the microbiological diagnosis of periprosthetic joint infection.
Biofilm
Chemical dislodgement
Diagnosis
Dithiothreitol
Prosthesis
Sonication
Journal
Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
31
10
2021
revised:
26
02
2022
accepted:
04
03
2022
pubmed:
9
4
2022
medline:
11
5
2022
entrez:
8
4
2022
Statut:
ppublish
Résumé
Sonication of explanted devices is well investigated method and was shown to improve the microbiological diagnosis of impant-associated infections by physical removal of bacterial biofilms. Recently, novel approach with chemical agents have been investigated for biofilm dislodgement such as dithiothreitol (DTT). We compared the biofilm dislodgement efficacy of chemical method (dithiothreitol, DTT) compared to the sonication procedure in the diagnosis of prosthetic joint infections (PJI). In a prospective cohort, 187 patients undergoing hip and knee prostheses explantation were included, of whom 94 were assigned for sonication and 93 for DTT group. Sonication showed better sensitivity (73.8%) than DTT (43.2%) for the diagnosis of PJI and comparable specificity (98% and 94.6%, respectively). We concluded that sonication provides a more reliable diagnosis of PJI and detects about 30% more pathogens compared to DTT system. The study was registered at ClinicalTrials.gov (NCT02530229).
Identifiants
pubmed: 35395437
pii: S0732-8893(22)00047-5
doi: 10.1016/j.diagmicrobio.2022.115679
pii:
doi:
Substances chimiques
Dithiothreitol
T8ID5YZU6Y
Banques de données
ClinicalTrials.gov
['NCT02530229']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
115679Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest Heraeus Medical (Hanau, Germany) provided the DTT diagnostic kits MicroDTTect system (4i Srl, Monza, Italy). The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.